Molecular Health - Dataome Technology

Accelerate drug development and reduce costs by exploring in depth the complete data and information landscape around your product.

• Understand the biology of complex disease and identify better target-disease relationships
• Investigate molecular disease subtypes to identify and address responder patient populations
• Reveal new promising targets for the development of novel therapies
• Augment the value of pipeline drug candidates and portfolio drugs
• Optimize clinical trial structure, size, and relevant study cohorts
• Anticipate risks and mitigate failure of candidates at clinical stage

• Proprietary data capture and structure creates an unmatched and evolving knowledge base
• In-house curation by biomedical experts to link and deliver otherwise inaccessible data
• Stringent data quality assurance via highly standardized data capture and assimilation
• Tailored design of in silico disease models to connect drug therapies to patient outcomes
• Disease agnostic knowledge base with in-depth focus on CNS diseases and oncology
• Access to real-world data from millions of patients to generate and validate relevant hypotheses
• An extended, powerful portfolio of advanced analytical and AI technologies
• Extensive quality certifications and medical device approval
• Proven and published [1–3] track record of successful projects with industry, academia and regulators